Some heart patients may be highly educated and understand recommended treatments. However, they do not appear to do any better at managing their own care related to heart failure as compared to less-educated patients.
Blood pressure changes during middle age may be more significant than they appear. An increase or decrease in blood pressure during that period can increase lifetime risk of heart disease and stroke.
Cancer patients and survivors just can't get a break it seems. Now, they have another increased risk to live with, according to newly published research.
Gilenya, a FDA-approved multiple sclerosis drug, had positive results in a late-stage clinical trial. The results may help ease safety concerns about the drug.
People with diabetes face the risk of a variety of health problems, especially heart-related problems. In fact, heart disease is the main cause of death among diabetes patients. So, how do patients avoid these risks?
Pfizer Inc. announced that a Phase 3 study for Lyrica (pregabalin) in patients with restless legs syndrome (RLS) met each of its three co-primary endpoints, showing significant benefit as compared with placebo and pramipexole.
Patients with Parkinson's Disease often suffer from depression. One drug that treats a number of Parkinson's physical symptoms may also help with some of the emotional complications of the disease.
